Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1083211.RAxYNK0z1R-cjlOfFJDvzJnQLyDRbwu3HIDV6NYlS2pBM130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1083211.RAxYNK0z1R-cjlOfFJDvzJnQLyDRbwu3HIDV6NYlS2pBM130_assertion type Assertion NP1083211.RAxYNK0z1R-cjlOfFJDvzJnQLyDRbwu3HIDV6NYlS2pBM130_head.
- NP1083211.RAxYNK0z1R-cjlOfFJDvzJnQLyDRbwu3HIDV6NYlS2pBM130_assertion description "[Increased RGS17 expression in some prostate and lung cancers has been demonstrated to support cancer progression, while reduced expression of RGS17 can lead to development of chemotherapeutic resistance in ovarian cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1083211.RAxYNK0z1R-cjlOfFJDvzJnQLyDRbwu3HIDV6NYlS2pBM130_provenance.
- NP1083211.RAxYNK0z1R-cjlOfFJDvzJnQLyDRbwu3HIDV6NYlS2pBM130_assertion evidence source_evidence_literature NP1083211.RAxYNK0z1R-cjlOfFJDvzJnQLyDRbwu3HIDV6NYlS2pBM130_provenance.
- NP1083211.RAxYNK0z1R-cjlOfFJDvzJnQLyDRbwu3HIDV6NYlS2pBM130_assertion SIO_000772 23734683 NP1083211.RAxYNK0z1R-cjlOfFJDvzJnQLyDRbwu3HIDV6NYlS2pBM130_provenance.
- NP1083211.RAxYNK0z1R-cjlOfFJDvzJnQLyDRbwu3HIDV6NYlS2pBM130_assertion wasDerivedFrom befree-2016 NP1083211.RAxYNK0z1R-cjlOfFJDvzJnQLyDRbwu3HIDV6NYlS2pBM130_provenance.
- NP1083211.RAxYNK0z1R-cjlOfFJDvzJnQLyDRbwu3HIDV6NYlS2pBM130_assertion wasGeneratedBy ECO_0000203 NP1083211.RAxYNK0z1R-cjlOfFJDvzJnQLyDRbwu3HIDV6NYlS2pBM130_provenance.